PuSH - Publication Server of Helmholtz Zentrum München: Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Wain, L.V.* ; Shrine, N.* ; Artigas, M.S.* ; Erzurumluoglu, A.M.* ; Noyvert, B.* ; Bossini-Castillo, L.* ; Obeidat, M.* ; Henry, A.P.* ; Portelli, M.A.* ; Hall, R.J.* ; Billington, C.K.* ; Rimington, T.L.* ; Fenech, A.G.* ; John, C.* ; Blake, T.* ; Jackson, V.E.* ; Allen, R.J.* ; Prins, B.P.* ; Campbell, A.* ; Porteous, D.J.* ; Jarvelin, M.R.* ; Wielscher, M.* ; James, A.L.* ; Hui, J.* ; Wareham, N.J.* ; Zhao, J.H.* ; Wilson, J.F.* ; Joshi, P.K.* ; Stubbe, B.* ; Rawal, R. ; Schulz, H. ; Imboden, M.* ; Probst-Hensch, N.M.* ; Karrasch, S. ; Gieger, C. ; Deary, I.J.* ; Harris, S.E.* ; Marten, J.* ; Rudan, I.* ; Enroth, S.* ; Gyllensten, U.* ; Kerr, S.M.* ; Polasek, O.* ; Kähönen, M.* ; Surakka, I.* ; Vitart, V.* ; Hayward, C.* ; Lehtimäki, T.* ; Raitakari, O.T.* ; Evans, D.M* ; Henderson, A.J.* ; Pennell, C.E.* ; Wang, C.A.* ; Sly, P.D.* ; Wan, E.S.* ; Busch, R.* ; Hobbs, B.D.* ; Litonjua, A.A.* ; Sparrow, D.W.* ; Gulsvik, A.* ; Bakke, P.S.* ; Crapo, J.D.* ; Beaty, T.H.* ; Hansel, N.N.* ; Mathias, R.A.* ; Ruczinski, I.* ; Barnes, K.C.* ; Bossé, Y.* ; Joubert, P.* ; van den Berge, M.* ; Brandsma, C.A.* ; Paré, P.D.* ; Sin, D.D.* ; Nickle, D.C.* ; Hao, K.* ; Gottesman, O.* ; Dewey, F.E.* ; Bruse, S.E.* ; Carey, D.J.* ; Kirchner, H.L.* ; Jonsson, S.* ; Thorleifsson, G.* ; Jonsdottir, I.* ; Gislason, T.* ; Stefansson, K.* ; Schurmann, C.* ; Nadkarni, G.* ; Bottinger, E.P.* ; Loos, R.J.* ; Walters, R.G.* ; Chen, Z.* ; Millwood, I.Y.* ; Vaucher, J.* ; Kurmi, O.P.* ; Li, L.* ; Hansell, A.L.* ; Brightling, C.* ; Zeggini, E.* ; Cho, M.H.* ; Silverman, E.K.* ; Sayers, I.* ; Trynka, G.* ; Morris, A.P.* ; Strachan, D.P.* ; Hall, I.P.* ; Tobin, M.D.*

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.

Nat. Genet. 49, 416-425 (2017)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metrics
Extra information

Chronic obstructive pulmonary disease (COPD) is characterized by reduced lung function and is the third leading cause of death globally. Through genome-wide association discovery in 48,943 individuals, selected from extremes of the lung function distribution in UK Biobank, and follow-up in 95,375 individuals, we increased the yield of independent signals for lung function from 54 to 97. A genetic risk score was associated with COPD susceptibility (odds ratio per 1 s.d. of the risk score (∼6 alleles) (95% confidence interval) = 1.24 (1.20-1.27), P = 5.05 × 10(-49)), and we observed a 3.7-fold difference in COPD risk between individuals in the highest and lowest genetic risk score deciles in UK Biobank. The 97 signals show enrichment in genes for development, elastic fibers and epigenetic regulation pathways. We highlight targets for drugs and compounds in development for COPD and asthma (genes in the inositol phosphate metabolism pathway and CHRM3) and describe targets for potential drug repositioning from other clinical indications.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

27.959

6.620

149

173